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A B S T R A C T
Objectives: The inﬂuence of gender-dependent metabolic risk factors on arterial stiffness has not been
fully determined. This study was performed to investigate the relationship between components of
metabolic syndrome and brachial-ankle pulse wave velocity (baPWV) according to gender.
Methods: A total of 537 subjects (54.4  7.5 years and 70.6% men) who underwent baPWV measurement
during routine check-ups were analyzed.
Results: BaPWV was 1363  229 cm/s in men and 1387  269 cm/s in women (p = 0.313). The prevalence of
metabolic syndrome was not different according to gender (23% in men versus 27% in women, p = 0.335). In
multiple linear regression analyses, after adjustment for age, baPWV was signiﬁcantly associated with systolic
and diastolic blood pressures, fasting glucose, and triglyceride in both genders. Waist circumference was
associated with baPWV in women but not in men. High-density lipoprotein levels were not associated with
baPWV in either gender. Subjects with metabolic syndrome had a higher baPWV than those without metabolic
syndrome for women aged <55 years, but not for all men and women aged 55 years. As the number of the
components of metabolic syndrome increased, baPWV increased proportionally in both genders. However, this
correlation was more strong in women than that in men (b = 0.408 versus b = 0.146 after adjustment for age).
Conclusion: In middle-aged Koreans, women showed stronger associations between each component of
metabolic syndrome and baPWV than men. The association of each component of metabolic syndrome to
arterial stiffness may differ between men and women.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Metabolic syndrome is associated with increased risk of
mortality, cardiovascular disease, and diabetes [1–3]. It has been
reported that about one-quarter of adults have metabolic syndrome,
and that its prevalence is increasing persistently [4]. Therefore,
metabolic syndrome is a big public health burden worldwide.
Arterial stiffness reﬂects vascular aging and atherosclerosis [5].
Increased arterial stiffness has been advocated as an independent
risk factor for cardiovascular mortality and morbidity [6–9].
Arterial stiffness can be measured using pulse wave velocity
(PWV). Although carotid-femoral PWV (cfPWV) is considered as
the gold standard measure of arterial stiffness, difﬁculty in
performing the test limits its clinical use, whereas, brachial-ankle* Corresponding author at: Division of Cardiology, Department of Internal
Medicine, Seoul National University Boramae Medical Center, Seoul National
University College of Medicine, 39 Boramae-gil, Dongjak-gu, Seoul 156-707,
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0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsPWV (baPWV) is performed more easily than cfPWV, so that it has
been used as an effective tool for screening vascular damage and
cardiovascular risk in various populations [10–14], and its
usefulness was demonstrated in a meta-analysis [6].
Metabolic risk factors lead to an increase in arterial stiffness.
There have been many studies on the association between
metabolic syndrome and arterial stiffness [15,16]. However, the
impact of gender on the association between metabolic syndrome
and arterial stiffness has not yet been fully assessed. This study was
performed to investigate the relationship between each compo-
nent of metabolic syndrome and baPWV according to gender.
Methods
Study subjects
Between October 2009 and July 2013, a total of 537 consecutive
subjects underwent baPWV measurement as a part of self-paid
health examination at Seoul National University Boramae Medical reserved.
Table 1
Baseline characteristics of study subjects.
Men (n = 379) Women (n = 158) p
Age (years) 53.8  7.5 55.9  7.5 0.004
Body mass index (kg/m2) 24.4  3.1 24.2  3.4 0.570
Body fat (%) 23.2  5.2 33.8  6.0 <0.001
Waist circumference (cm) 84.4  7.7 77.5  9.1 <0.001
Hip circumference (cm) 95.1  5.6 93.5  6.5 0.003
Hypertension, n (%) 125 (34.5) 44 (29.1) 0.236
Diabetes, n (%) 39 (10.8) 13 (8.6) 0.459
Dyslipidemia, n (%) 74 (20.4) 39 (25.8) 0.180
Current smoking, n (%) 125 (38.0) 8 (6.5) <0.001
Previous CAD, n (%) 11 (3.0) 2 (1.3) 0.363
Previous stroke, n (%) 5 (1.4) 3 (2.0) 0.699
SBP (mmHg) 123  13 118  16 <0.001
DBP (mmHg) 82.3  9.7 78.5  10.0 <0.001
Hemoglobin (g/dL) 15.3  0.9 13.2  0.8 <0.001
Fasting plasma glucose
(mg/dL)
98.3  18.5 96.1  18.3 0.209
Uric acid (mg/dL) 5.76  1.29 4.44  1.09 <0.001
Total cholesterol (mg/dL) 191  32 200  41 0.012
LDL cholesterol (mg/dL) 119  31 125  39 0.141
HDL cholesterol
(mg/dL)
48.7  11.9 54.9  12.0 <0.001
Triglyceride (mg/dL) 113  61 103  54 0.059
Estimated GFR
(mL/min/1.73 m2)
81.6  13.1 83.0  14.9 0.254
C-reactive protein
(mg/dL)
0.12  0.20 0.15  0.29 0.306
baPWV (cm/s) 1363  229 1387  269 0.313
CAD, coronary artery disease; SBP, systolic blood pressure; DBP, diastolic blood
pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; GFR,
glomerular ﬁltration rate; baPWV, brachial-ankle pulse wave velocity.
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There were no exclusion criteria. All study subjects were relatively
healthy and medically stable at the time of examination.
Information on medical history, including hypertension, diabetes,
dyslipidemia, stroke, and coronary artery disease, and smoking
habits, were obtained using a standardized questionnaire. All
subjects underwent measurement of body weight, height, and
waist and hip circumference. Body fat composition was also
obtained using a bioimpedance spectroscopy analyzer (InBody
720; Biospace Co., Ltd., Seoul, Korea), and was presented as
percentages (%). Body mass index (BMI) was calculated as body
weight (kg) divided by the square of body height (m). Blood
pressure was measured on the right upper arm using an automatic
digital blood pressure monitor. Venous blood was collected from
the antecubital vein in the morning after overnight fasting. The
blood levels of hemoglobin, fasting glucose, uric acid, total
cholesterol, low-density lipoprotein (LDL) cholesterol, high-
density lipoprotein (HDL) cholesterol, triglyceride, serum creati-
nine, and C-reactive protein were measured. Estimated glomerular
ﬁltration rate (eGFR) was calculated using following formula:
eGFR = 175  serum creatinine (mg/dL)  1.154  age  0.203
(0.742, if woman) [17]. Approval for the study protocol was
obtained from the Institutional Review Board of Seoul National
University Boramae Medical Center (Seoul, Korea).
Metabolic syndrome
Metabolic syndrome was deﬁned as a waist circumference level
85 cm in women and 90 cm in men and 2 or more of the
following four risk factors: (1) an elevated systolic/diastolic blood
pressure of 130/85 mmHg, or previously diagnosed hyperten-
sion, (2) an elevated triglyceride level of 150 mg/dL, or speciﬁc
treatment of this lipid abnormality, (3) a reduced HDL cholesterol
level <40 mg/dL in men and <50 mg/dL in women, and speciﬁc
treatment of this lipid abnormality, and (4) an elevated fasting
glucose level of 100 mg/dL or previously diagnosed type 2
diabetes mellitus [18].
baPWV measurement
The baPWV measurement protocol has been described previ-
ously [19]. All study subjects had received no drug treatment on
the day of measurement. Patients were examined in the supine
position after resting for ﬁve or more minutes. BaPWV was
measured using a volume-plethysmographic apparatus (VP-1000;
Colin Co., Ltd., Komaki, Japan) in accordance with the manufac-
turer’s instructions. Cuffs were wrapped on both arms and ankles.
Phonogram, pulse volume waveform, blood pressure, and heart
rate were simultaneously recorded. PWV was calculated by
measuring the time for the pulse wave to travel between the
brachial and posterior tibial arteries (velocity = distance/time). The
mean value between left and right baPWV was used for study
analysis. All measurements were performed by the same experi-
enced operator blinded to patients’ information.
Statistical analysis
Continuous variables were presented as mean  standard
deviation (SD), and categorical variables were expressed as percen-
tages. Continuous variables were compared using Student’s t-test,
and categorical variables were compared using the Chi-square test
between both genders. Pearson’s correlation analysis and scatter
plots were used to show the association between two continuous
parameters. Multiple linear regression analyses were performed to
assess associations between baPWV and each component of
metabolic syndrome, independent of age. The interactions betweenthe number of metabolic components and gender in relation to
baPWV were assessed using cross-product term in the regression
model. A p-value of <0.05 was considered statistically signiﬁcant. All
statistical analyses were conducted using SPSS 18.0 (Chicago, IL, USA).
Results
Baseline characteristics
Of the enrolled subjects, 379 (70.6%) were men. Baseline clinical
characteristics according to gender are shown in Table 1. Women
were older than men (55.9  7.5 years versus 53.8  7.5 years,
p = 0.004). BMI was similar between both genders. Waist and hip
circumferences were greater in men than in women. The percentage
of body fat was higher in women than in men. The prevalence of
traditional risk factors, including hypertension, diabetes, dyslipide-
mia, previous coronary artery disease, and stroke, were similar in
both genders. The proportion of current smokers was signiﬁcantly
higher in men than in women. Systolic and diastolic blood pressures
were higher in men than in women. Laboratory test results showed
that men had a higher level of uric acid and a lower level of HDL
cholesterol than women. Total cholesterol level was higher in women
than in men. BaPWV values were 1363  229 cm/s in men and
1387  269 cm/s in women (p = 0.313). The distributions of baPWV of
men and women are shown in Fig. 1.
Association between age and baPWV
Although it is not a component of metabolic syndrome, age has
been reported to be one of the most powerful indicators of arterial
stiffness [20]. Our results also showed that there were signiﬁcant
positive linear correlations between age and baPWV in both
genders (r = 0.411 in men and 0.495 in women, p < 0.001 for each)
(Fig. 2).
Fig. 1. Distribution of brachial-ankle PWV of study subjects. PWV, pulse wave velocity.
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Multiple linear regression analyses were used to control the
effect of age on baPWV (Table 2). Systolic (b = 0.333, p < 0.001) and
diastolic (b = 0.262, p < 0.001) blood pressures, fasting plasma
glucose (b = 0.138, p = 0.003), HbA1c (b = 0.128, p = 0.007), and
triglyceride (b = 0.109, p = 0.021) were signiﬁcantly associated
with baPWV in men. Waist circumference was not associated with
baPWV in men (b = 0.026, p = 0.576). In women, waist circum-
ference (b = 0.388, p < 0.001), systolic (b = 0.487, p < 0.001) and
diastolic (b = 0.329, p < 0.001) blood pressures, fasting plasma
glucose (b = 0.227, p = 0.002), HbA1c (b = 0.163, p = 0.029), and
triglyceride (b = 0.190, p = 0.010) were signiﬁcantly associatedFig. 2. Associations between brachial-ankle PWV and age according to gender. PWV,
pulse wave velocity.with baPWV. HDL cholesterol was not associated with baPWV in
either gender (p > 0.05 for each). Simple linear correlations
between waist circumference and baPWV according to gender
are shown in Fig. 3.
Associations between baPWV and metabolic syndrome and its
components according to gender
The prevalence of metabolic syndrome was 22.7% in men
(n = 86) and 26.6% (n = 42) in women (p = 0.335). Study subjects
were stratiﬁed according to their mean age (<55 versus 55 years)
and gender, and we compared baPWV value in relation to
metabolic syndrome and its components. For the whole subjects,
those with metabolic syndrome had a higher baPWV than those
without metabolic syndrome regardless of their ages. The same
was seen for women aged <55 years but not for all men and
women aged 55 years (Fig. 4). High blood pressure was
associated with elevated baPWV in both genders, and central
obesity was associated with elevated baPWV in women aged <55
years but not in all men and women aged 55 years. High plasma
glucose level was associated with elevated baPWV in men but not
in women. HDL and triglyceride were not associated with baPWV
in either gender in these analyses (Fig. 5). As the number of the
components of metabolic syndrome increased, baPWV increased
proportionally in both genders (p < 0.001 for each). However, this
correlation was more signiﬁcant in women than in men (b = 0.408Table 2
Multiple linear regression analyses showing gender-speciﬁc correlations between
brachial-ankle pulse wave velocity and each component of metabolic syndrome
after controlling for age.
Variable Men Women
b p b p
Waist circumference 0.026 0.576 0.388 <0.001
Systolic blood pressure 0.333 <0.001 0.487 <0.001
Diastolic blood pressure 0.262 <0.001 0.329 <0.001
Fasting plasma glucose 0.138 0.003 0.227 0.002
Hemoglobin A1c 0.128 0.007 0.163 0.029
Triglyceride 0.109 0.021 0.190 0.010
High-density lipoprotein cholesterol 0.057 0.228 0.020 0.782
Fig. 3. Simple linear correlations between waist circumference and brachial-ankle PWV according to gender. PWV, pulse wave velocity; r, correlation coefﬁcient.
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signiﬁcant interaction between the number of metabolic compo-
nents and gender in relation to baPWV (p for interaction = 0.004),
indicating that the associations were stronger in women than in
men (Fig. 6B).
Discussion
Our results showed that elevated baPWV is associated with
metabolic syndrome in both genders; however, each component of
metabolic syndrome has a different impact on baPWV according to
gender. Women have a stronger association of baPWV with
metabolic syndrome and its components than men.
Associations between baPWV and metabolic syndrome
There have been many studies showing a positive association
between elevated baPWV and metabolic syndrome [15,16]. Each
component of metabolic syndrome plays a role as a risk factor of
cardiovascular disease by promoting inﬂammation, thrombosis,Fig. 4. Associations between brachial-ankle PWV and metabolic syndrome
according to gender and ages. PWV, pulse wave velocity; MetS, metabolic
syndrome. *p < 0.05 versus MetS (–).and atherosclerosis [21]. These unfavorable effects lead to vascular
damage and consequent poor cardiovascular outcome, which is
reﬂected by increased arterial stiffness. In addition, it has been
reported that there is close interaction between metabolic
derangement and endothelial dysfunction, which is a hallmark
of atherosclerosis [22]. Therefore, in the setting of metabolic
syndrome, it is possible to predict that elevated baPWV is
potentially caused by cumulative effects of risk factors of
metabolic syndrome. This study also demonstrates a positive
relationship between high baPWV and metabolic syndrome:
subjects with metabolic syndrome had a higher baPWV than
those without, and as the number of the components of metabolic
syndrome increased, baPWV value also increased proportionally in
both genders. Our results add to the body of evidence that
metabolic syndrome is a risk factor of arterial stiffening.
Gender-dependent associations between baPWV and each component
of metabolic syndrome
There have been a few studies regarding the relationship
between metabolic syndrome and arterial stiffness in relation to
gender. Weng et al. [23] found that different metabolic variables
and components of metabolic syndrome have distinct impacts on
baPWV in age- and gender-dependent manners. They showed that
linear associations between the number of the components of
metabolic syndrome and baPWV are stronger in women than in
men. Another study of 8300 Chinese subjects has also shown that
the metabolic syndrome and its components affect arterial
stiffness more severely in women than in men [24]. Nishida
et al. [25] demonstrated similar ﬁndings that an increase in the
number of clustering metabolic syndrome components is more
signiﬁcantly associated with worsening of baPWV. Consistent with
these ﬁndings, our results showed that linear associations between
the number of the components of metabolic syndrome and baPWV
were stronger in women than in men suggesting more pronounced
effects of metabolic syndrome on arterial stiffness in women than
in men. In addition, we also showed different associations of
metabolic syndrome and its components with baPWV according to
age groups. In particular, baPWV was higher in young women
(aged <55 years) with metabolic syndrome than those without;
however, baPWV was not different by metabolic syndrome in older
women (aged 55 years). The same result was shown in the
Fig. 5. Associations between brachial-ankle PWV and each component of metabolic syndrome according to gender and ages. Comparisons of baPWV values between subjects
with and without waist circumference (A), blood pressure (B), fasting glucose (C), high-density lipoprotein cholesterol (D), and triglyceride (E) meeting diagnostic criteria of
metabolic syndrome in relation to gender and ages. PWV, pulse wave velocity; MetS, metabolic syndrome; WC, waist circumference; BP, blood pressure; Glu, glucose; HDL,
high-density lipoprotein; TG, triglyceride. *p < 0.05 versus MetS (–).
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consider that most Korean women experience menopause around
the age of 50 years [26], these results may suggest the important
role of hormonal status on the associations between metabolic
syndrome and arterial stiffness in women.
The mechanism on the gender-speciﬁc effects of metabolic
syndrome and its components on arterial stiffness is uncertain.Traditionally, menopause and estrogen status have been proposed
as the reason for gender difference in cardiovascular risk and
complications [27,28]. Estrogen affects vascular structure and
function [29] and hormonal replacement therapy reduces arterial
stiffness in post-menopausal women [30]. Different mechanical
properties of arteries between men and women have been
reported [31]. Many investigations reported that women have a
Fig. 6. Associations between brachial-ankle PWV and number of metabolic syndrome components according to gender. Age-adjusted associations between brachial-ankle
PWV and number of metabolic syndrome components according to gender (A), and interaction between the number of metabolic syndrome components and gender in
relation to brachial-ankle PWV (B). PWV, pulse wave velocity.
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not different according to gender. The old age of our study
population may explain this discrepancy. In the elderly, baPWV
levels become similar because estrogen, which has a vascular
protective effect, declines after menopause [24,30,33]. Regarding
metabolic syndrome, it has been speculated that reduced
accumulation of fat within the intra-abdominal area may play a
protective role in young women. However, with aging, the decline
in ovarian function reduces estrogen production which is
responsible for menopause-related metabolic changes and central
obesity [28]. Central obesity plays a pivotal role in the develop-
ment of cardiometabolic disease, and is also an essential
component for the diagnosis of metabolic syndrome. We found
evidence of gender interactions in that central obesity was
positively associated with arterial stiffness independently of age
in women but not men, which is consistent with ﬁndings of aprevious study [23]. The higher amount of hepatic-free fatty acid
delivery derived from lipolysis of visceral adipose tissue and
differences in adipokine secretion and synthesis have been
suggested as another reason explaining gender difference
[28,34]. Longevity and later onset of cardiovascular disease in
women may also contribute to gender differences [28].
Clinical utility of baPWV
Although cfPWV is considered the most reliable index of arterial
stiffness, there is some strength of baPWV compared to cfPWV.
BaPWV is easy to perform, and is well correlated with cfPWV [11]
and aortic stiffness obtained by invasive recording [35]. In
addition, the validity and usefulness of baPWV have been proved
by applying it in the noninvasive assessment of atherosclerosis,
and by employing it as a prognostic marker in the prediction of
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subgroups with certain disease conditions [10–14]. In particular,
because of its simplicity and short measurement time, baPWV is
more suitable for screening a large population than other methods
for arterial stiffness. Before the onset of overt cardiovascular
disease, the metabolic syndrome is often present. Therefore,
identiﬁcation and management of the metabolic syndrome are
crucial for the prevention of cardiovascular disease. From this point
of view, baPWV would be a useful tool for the assessment of
subclinical arterial alterations in metabolic syndrome.
Study limitations
In addition to the retrospective study design, our study has
some limitations. First, our results do not infer causal relationships
between metabolic syndrome and baPWV because of its observa-
tional and cross-sectional study design. Second, our study
population consisted solely of middle-aged Koreans, so generali-
zation to other populations is limited. Third, the study may have
been underpowered to detect some gender differences because of
the relatively small number of subjects. Finally, vasoactive drugs
affecting baPWV values were not identiﬁed.
Conclusions
The effects of metabolic syndrome and its components on
arterial stiffness are more pronounced in women than in men.
When interpreting study results, this gender effect should be
considered. In addition, more attention should be paid to women
with metabolic syndrome. Prospective studies with a large sample
size would be required to conﬁrm these ﬁndings.
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